ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 39 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $167,000 | -51.0% | 200,000 | -50.0% | 0.02% | -29.4% |
Q3 2018 | $341,000 | +41.5% | 400,000 | +60.0% | 0.03% | +13.3% |
Q2 2018 | $241,000 | +4.3% | 250,000 | 0.0% | 0.03% | +3.4% |
Q1 2018 | $231,000 | +7.4% | 250,000 | 0.0% | 0.03% | +3.6% |
Q4 2017 | $215,000 | -6.5% | 250,000 | -16.7% | 0.03% | +3.7% |
Q4 2016 | $230,000 | -6.9% | 300,000 | 0.0% | 0.03% | -6.9% |
Q3 2016 | $247,000 | -34.0% | 300,000 | -29.4% | 0.03% | -40.8% |
Q2 2016 | $374,000 | -1.6% | 425,000 | 0.0% | 0.05% | +2.1% |
Q1 2016 | $380,000 | – | 425,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |